Aclaris Therapeutics gained 2.16% in the last trading day ( Friday, 20th Sep 2019 ), rising from $1.39 to $1.42 During the day the stock fluctuated 12.41% from a day low at $1.37 to a day high of $1.54. The price has been going up and down for this period, and there has been a 40.59% gain for the last 2 weeks. Volume fell in the last day by -0.74 million shares and in total, 1.76 million shares bought and sold for approximately $2.50 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Quick summary:
- 30 day high of the ACRS stock price was $2.08 and low was $0.85.
- 90 day high was $4.67 and low was $0.74.
- 52 week high for Aclaris Therapeutics - $15.98 and low - $0.74.
Trend
Aclaris Therapeutics lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.69 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -57.70% during the next 3 months and, with 90% probability hold a price between $-0.15 and $0.71 at the end of this period.
Signals
Only positive signals in the chart today. Aclaris Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $1.35 and $1.05. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday September 19, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Relative Strength Index (RSI)
RSImin/max Values: [ 20 - 75 ]
RSI14 is 63 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Aclaris Therapeutics finds support from accumulated volume at $1.39.
Risk
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.17 between high and low, or 12.41%. For the last week, the stock has had a daily average volatility of 17.95%.
Our recommended stop-loss: $1.32 (-6.87%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 1 days ago.)
17.95 %
Average volatilityOverall risk:
Very Low Low Medium High Very High
Evaluation
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Buy Candidate.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Trading With Moving Average
As an investor, you always seek to understand what other... Full ArticlePivot Points
Pivot Points refer to points of significant change. As a... Full ArticleAccumulated Volume - Support and Resistance
Volume is perhaps the best indicator of all and should... Full ArticleVolume - The Indicator You Really Need to Know
Many new traders getting into the world of technical analysis... Full ArticleWe Give Back!
In 2016 StockInvest.us donated to NGO Goodwill projects to help purchase medical... Full ArticleBetter Buy: Amazon vs. Facebook
Amazon's stock slipped 21% over the past six months, as... Full ArticleProudly made at
